Los mejores médicos de CyberKnife para tumor cerebral en el extranjero — Página 2

El profesor Itzhak Fried es un neurocirujano y neurocientífico reconocido mundialmente, formado en Stanford y Yale.

• Especializado en cirugías cerebrales avanzadas tanto para niños como para adultos
• Pionero en enfoques innovadores para el tratamiento y la investigación de la epilepsia
• Desarrolló programas modernos para el manejo de pacientes con epilepsia
• Enseña en las mejores facultades de medicina, incluidas UCLA y Yale

La Dra. Nichakorn Seehirunwong es radióloga diagnóstica especializada en la interpretación de imágenes médicas para la planificación precisa del tratamiento con CyberKnife en el Hospital Intrarat.

• Doctora en Medicina por la Facultad de Medicina de la Universidad Príncipe de Songkla
• Certificado en Radiología Diagnóstica por la Universidad Príncipe de Songkla
• Experta en procedimientos guiados por imagen para la planificación del tratamiento
• Actualmente se desempeña como radióloga diagnóstica en el Hospital Intrarat

Especialista en CyberKnife para tumores cerebrales con formación avanzada en la Universidad de Duke. Dirige el Servicio de Radiación para Tumores del Sistema Nervioso en el Centro Médico de Tel Aviv.

• Más de 22 años de experiencia enfocada en radioterapia para tumores cerebrales
• Formado en radiocirugía en el Duke University Medical Center
• Ha publicado 15 artículos profesionales sobre neurooncología
• Miembro activo de la Sociedad Internacional de Neurooncología

El Prof. Margalit Navo ha realizado más de 70 cirugías exitosas de meningioma y más de 100 procedimientos de tumores de base de cráneo en el Centro Médico Sourasky.

• Dirige el Departamento de Neurocirugía en Ichilov
• Especializado en la extirpación endoscópica mínimamente invasiva de tumores
• Formado en cirugía avanzada de base de cráneo en EE. UU.
• Miembro de la North American Skull Base Society

Especialista en cirugía de tumores cerebrales con enfoque en tratamientos con CyberKnife en el complejo hospitalario Medical Park Antalya.

• Más de 35 años de experiencia en neurocirugía
• Experto en cirugía de tumores cerebroespinales y procedimientos de aneurismas
• Formado en la Universidad de Estambul, una de las mejores facultades de medicina de Turquía
• Ganador del premio de tesis del Dr. Cengiz Çetin por investigación en neurocirugía

El Prof. Serdal Gungor se especializa en neurología pediátrica y cuenta con una amplia experiencia académica y clínica.

• Formación de subespecialidad en neurología pediátrica en la Universidad Hacettepe
• Más de _doctor_9534_años_ de experiencia en neurología pediátrica
• Profesor en la Facultad de Medicina de la Universidad İnönü
• Experiencia en trastornos neurológicos pediátricos

El Dr. Han Yeongmin es neurocirujano (MD, PhD). Es director médico y director del Centro de Neurocirugía del Hospital St. Mary’s de Incheon. Trata enfermedades cerebrovasculares y trastornos de los nervios periféricos. También se especializa en tumores cerebrales y cirugía de base de cráneo. Las afecciones incluyen ictus, hemorragia cerebral, infarto cerebral y enfermedad de Moyamoya. Realiza PEN, PNP y SNB. También ofrece discectomía microscópica y endoscópica, reemplazo de disco artificial, MIS-TLIF/fusión espinal mínimamente invasiva y vertebroplastia.

Obtuvo el título de médico (MD) y el doctorado (PhD) en la Universidad Católica de Corea. Fue profesor visitante en cirugía cerebrovascular y de base de cráneo en el Barrow Neurological Institute (Phoenix, Arizona, EE. UU.). También trabajó en el Harborview Medical Center, University of Washington (Seattle, EE. UU.).

Entre sus publicaciones figura la coautoría del capítulo 52 del Textbook of Korean Cerebrovascular Surgery. También es coautor de Acoustic Neuroma Oncology. Es miembro de pleno derecho de KNS, KSCVS, KSBS, KBTS, KNTS, KSNS y KSPNS.

Especializado en Oncología Médica con enfoque en tratamientos avanzados. El Dr. Alemdar cuenta con una rigurosa formación académica en instituciones líderes.

• Graduado de la Facultad de Medicina de la Universidad de Kocaeli
• Completó su especialización en Oncología Médica en la Universidad de Akdeniz
• Trabajó en el Hospital Universitario de Akdeniz, una de las mejores instalaciones médicas de Turquía
• Miembro de la comunidad de oncología médica de Turquía

Jefe de Neurocirugía en el Hospital Infantil SJD de Barcelona – El Dr. Hinojosa es un neurocirujano pediátrico de primer nivel especializado en tratamientos mínimamente invasivos de tumores cerebrales.

• Más de _doctor_2775_ años de experiencia en neurocirugía pediátrica
• Especializado en neurooncología y neuroendoscopia
• Presidente de la Sociedad Española de Neurocirugía Pediátrica
• Formado en el Montefiore Medical Center en EE. UU.
• Autor de 93 publicaciones científicas sobre neurocirugía

El Dr. Yaacov Lawrence, MA, MBBS, MRCP, es jefe del Departamento de Oncología Radioterápica del Centro Médico Sheba. Cuenta con casi 30 años de experiencia en radioterapia de precisión y neurooncología.

Es experto en radioterapia avanzada y radiocirugía. Realiza radiocirugía estereotáctica para tumores cerebrales. Dirige el Programa de Cáncer Gastrointestinal de Sheba. También ofrece tratamiento de precisión para los cánceres de pulmón y próstata. Fue pionero en la radiocirugía del plexo celíaco para el dolor intenso por cáncer de páncreas.

Formación y credenciales: MA y MBBS (Cambridge y UCLH); MRCP (RCP); beca en Oncología Radioterápica (Thomas Jefferson University). Entre sus honores figuran el ASCO Young Investigator Award y ser Miembro de ASTRO (FASTRO). Ha publicado más de 280 trabajos. Es director del Centro de Oncología Radioterápica Traslacional y profesor asociado en la Universidad de Tel Aviv.

_doctor_2825_años_ de experiencia en neurocirugía – El Dr. Andry Key se especializa en el tratamiento de tumores cerebrales en el Hospital Universitario Hadassah.

• Formado en la Universidad de Oxford y la Cleveland Clinic
• Jefe de Neurocirugía en el Royal Melbourne Hospital
• Galardonado con el Premio Ronald Bittner de la Asociación Americana de Neurocirujanos
• Miembro de múltiples sociedades neuroquirúrgicas internacionales

Especializado en el tratamiento de tumores cerebrales mediante CyberKnife en los hospitales Büyük Anadolu.

• Experto en cirugía de aneurismas e hipófisis
• Especialista en cirugía de columna y fracturas vertebrales
• Con experiencia en cirugía de nervios periféricos

Zhang Jinshan, male, China’s First M.D. in the Radiation Medicine, CCI (Chinese College of Interventionalists) Master Interventionalist, Director of the Department of Former Radiological Diagnosis at Chinese PLA General Hospital(No.3 in China) Ph.D. of Medicine, Nagasaki University, Japan.

1980–1985: Completed doctoral studies at Nagasaki University, Japan

1968–present: Department of Radiology, Chinese PLA General Hospital

1988: Third Prize of the Military Science and Technology Progress Award

1989–present: Member of Radiological Society of North America(RSNA)

1990–2009: Standing Committee Member of the Radiology and Therapeutic Radiology Committee of the PLA

1991: Second Prize of the Military Science and Technology Progress Award

1992–2008: Group Leader of the Group of Intervention of Chinese Journal of Radiology

1992–2015: Standing Editorial Board Member and Editorial Board Member of Journal of Interventional Radiology

1993: Granted the Lifetime Special Government Allowance of the State Council

1993–2012: Deputy Chief Editor of Chinese Journal of Medical Image Technology

1994: Third Prize of the Military Science and Technology Progress Award

1997: Second Prize of the Military Science and Technology Progress Award

1997–2009: Standing Member of Chinese Society of Radiology

1999: Third Prize of the Military Science and Technology Progress Award

1999–2010: Deputy Director Member of Chinese Society of Interventional Oncology

2002: Second Prize of the Military Science and Technology Progress Award

2005: Third Prize of the Military Science and Technology Progress Award

Member of Radiological Society of North America(RSNA)

Standing Member of Chinese Society of Radiology

Group Leader of the Group of Intervention of Chinese Journal of Radiology

Deputy Director Member of Chinese Society of Interventional Oncology

Director Member of Beijing Medical Association Society of Interventional Radiology

Deputy Chief Editor of Chinese Journal of Medical Image Technology

Standing Member of Professional Committee of Radiological Medicine of the Chinese People’s Liberation Army

Standing Editorial Board Member and Editorial Board Member of Journal of Interventional Radiology

Awarded the Special Government Allowance of the State Council

Awarded three Second Prizes and four Third Prizes for Military Science and Technology Progress.

Awarded the honorary title of “Chinese College of Interventionalists(CCI) Master Interventionalist”

Led multiple national and provincial/ministerial scientific research projects, including two projects funded by the National Natural Science Foundation of China and two projects funded by the Department of Science and Technology of Sichuan Province.

In the pioneering development of interventional medicine in China, Zhang Jinshan has been an indispensable founder and leading figure. As China’s first overseas-trained doctoral graduate in radiological medicine, he returned to China in the 1980s after completing his studies abroad and introduced cutting-edge international interventional technologies to the country. Over more than four decades of dedicated practice and research, he has helped propel Chinese interventional medicine from its infancy to a position at the forefront of the global field through his exceptional clinical expertise and profound academic accomplishments.

Professor Zhang Jinshan has long been dedicated to the field of medical imaging and has developed distinctive expertise in selective and superselective interventional diagnosis and treatment for solid tumors such as liver cancer, demonstrating exceptional technical proficiency and profound academic accomplishment. Beginning in the 1990s, he led his team in pioneering the clinical application and research of TIPSS and B-ORTO in China, filling major gaps in the domestic field and opening new paths for the interventional management of gastrointestinal bleeding caused by portal hypertension secondary to liver cirrhosis. In addition, he has made groundbreaking contributions to the interventional diagnosis and treatment of peripheral vascular diseases, as well as to preoperative embolization for spinal tumors.

In the field of liver cancer treatment, Professor Zhang Jinshan not only led the development of standardized treatment protocols for liver cancer but also pioneered Transcatheter Arterial Chemoembolization with temporary Hepatic Vein Thrombosis (TACE-THVO) for primary liver cancer, bringing the efficacy of interventional therapy to a new level. In recognition of his outstanding clinical and scientific contributions, he was awarded the honorary title of “Chinese Master of Interventional Radiology” at the 2019 annual conference of the Chinese College of Interventionalists.

Professor Zhang Jinshan is not only a master clinician but also a driving force in the development of the discipline and a dedicated mentor in talent cultivation. He led his team in establishing one of China’s premier interventional therapy centers. As a doctoral supervisor, he has trained a large number of outstanding specialists and future leaders in interventional medicine, with many of his students and protégés now serving across the country. Academically, he has led multiple key national and military research projects, published more than 300 academic papers, and served as chief editor of three monographs, making remarkable contributions to the establishment of China’s academic framework for interventional medicine and the nationwide dissemination of its technologies.

From the laboratory to the operating room, and from academic podiums to grassroots hospitals, Professor Zhang Jinshan has consistently upheld the principles of “pioneering, innovation, pragmatism, and compassion". He has devoted his life to fulfilling the mission of a physician—relieving patients’ suffering through minimally invasive techniques and advancing the discipline through academic excellence—thereby establishing himself as a truly towering figure and one of the foremost authorities in the field of interventional medicine in China.

Professor Zhang Jinshan’s Academic Achievements

Professor Zhang Jinshan has achieved prolific academic accomplishments, having published over 300 academic papers covering areas such as interventional therapy for liver cancer, minimally invasive treatment of portal hypertension, interventional treatment of vascular diseases, and tumor ablation.

Selected Publications by Professor Zhang Jinshan

1. Zhang Jinshan, Wang Maoqiang. Experiments and Clinical Studies of transjugular intrahepatic portosystemic stent shunt (TIPSS). Chinese Journal of Radiology, 1993，27（6）：361-365.

Professor Zhang Jinshan is the first author. This is one of the early research papers in China that systematically elaborates on the TIPSS technique. Through animal experiments and clinical case analysis, it confirmed that TIPSS is a safe and effective minimally invasive method for treating portal hypertension and its complications, laying an important foundation for the promotion and application of this technique in China.

2.Zhang Jinshan, Li Huai. Clinical study on transcatheter arterial embolization with temporary hepatic vein occlusion for the treatment of primary liver cancer.Chinese Journal of Radiology, 1996，30（8）：521-524.

Professor Zhang Jinshan is the first author. He innovatively proposed the technique of "transcatheter arterial embolization with temporary hepatic vein occlusion." Clinical results demonstrated that this method can significantly increase the drug concentration within liver cancer lesions, reduce damage to normal liver tissue, and effectively improve the therapeutic outcomes for intermediate and advanced liver cancer, providing a novel strategy for the interventional treatment of liver cancer.

3. Zhang Jinshan, Wang Maoqiang, Li Huai. Interventional treatment of Budd-Chiari syndrome. Chinese Journal of Medical Imaging Technology, 1998，14（3）：189-191.

Professor Zhang Jinshan is the first author. This paper systematically summarizes the early experience in interventional treatment of Budd-Chiari syndrome in China, elaborating in detail on the key operational points and therapeutic efficacy of techniques such as percutaneous transluminal angioplasty and stent placement. It confirms that interventional therapy is the preferred minimally invasive method for Budd-Chiari syndrome, promoting the standardized development of treatment for this disease.

4.Zhang Jinshan, Li Huai, Wang Maoqiang. Clinical value of superselective hepatic arterial chemoembolization in the treatment of hypovascular liver cancer. Chinese Journal of Radiology, 2000，34（5）：335-337.

Professor Zhang Jinshan is the first author. Addressing the challenges in interventional treatment of hypovascular liver cancer, this paper explores the clinical efficacy of superselective hepatic arterial chemoembolization. The results indicate that this technique can precisely target the lesions and improve the treatment response rate, providing an important clinical basis for the interventional treatment of hypovascular liver cancer.

5. Zhang Jinshan, Li Huai, Wang Maoqiang. Interventional treatment of peripheral vascular stenosis and occlusion.Chinese Journal of Radiology, 2002，36（7）：612-614.

Professor Zhang Jinshan is the first author. This paper summarizes the interventional treatment experience of over 400 patients with peripheral vascular stenosis and occlusion, analyzing the indications and efficacy of techniques such as balloon angioplasty and stent placement. It confirms that interventional therapy is a safe and effective approach for peripheral vascular diseases, providing practical support for its clinical promotion.

6.Zhang Jinshan, Li Huai, Wang Maoqiang. Clinical application of CT-guided percutaneous puncture ablation in the treatment of abdominal tumors. Chinese Journal of Medical Imaging Technology, 2004，20（9）：1395-1397.

Professor Zhang Jinshan is the first author. This paper explores the application value of CT-guided percutaneous puncture techniques such as radiofrequency ablation and chemical ablation in the treatment of abdominal tumors. The clinical results show that this method is minimally invasive with reliable efficacy, offering a minimally invasive treatment option for patients with inoperable abdominal tumors.

7.Zhang Jinshan, Wang Maoqiang, Li Huai. Advances in the application of interventional therapy for benign prostatic hyperplasia. Chinese Journal of Radiology, 2006，40（8）：876-878.

Professor Zhang Jinshan is the corresponding author. This paper systematically reviews the cutting-edge advances in interventional therapy for benign prostatic hyperplasia, including the principles, procedures, and efficacy of techniques such as prostatic artery embolization and stent placement, providing new insights for the minimally invasive treatment of benign prostatic hyperplasia.

8.Zhang Jinshan, Li Huai, Wang Maoqiang. Discussion on the standardization of interventional therapy for liver cancer. Chinese Journal of Practical Surgery, 2008，28（10）：856-858.

Professor Zhang Jinshan is the corresponding author. Drawing on years of clinical experience and research findings, he led the discussion on standardized protocols for interventional therapy of liver cancer, covering key aspects such as preoperative assessment, treatment modality selection, and postoperative management, providing important references for the formulation of clinical guidelines for interventional therapy of liver cancer in China.

Professor Zhang Jinshan co-authored monographs

1. Interventional Radiology (People's Military Medical Press, 1995): The first monograph in China to systematically discuss the theories and techniques of interventional radiology. It comprehensively elaborates on the interventional diagnosis and treatment system for tumors, vascular diseases, and non-vascular diseases, becoming a classic essential textbook for interventional physicians in China.

2.Interventional Therapy for Liver Cancer (People's Health Press, 2001): Focusing on minimally invasive interventions for liver cancer, this book systematically summarizes techniques such as TACE, ablation, and vascular intervention, refines operational standards and the prevention and management of complications, and promotes the standardization of interventional therapy for liver cancer.

3.Interventional Treatment of Portal Hypertension (Science Press, 2005): This book systematically elaborates on minimally invasive techniques for portal hypertension, such as TIPSS and B-ORTO, covering experimental research, clinical procedures, long-term follow-up, and efficacy evaluation, filling the gap in monographs on interventional treatment of portal hypertension in China.

Professor Zhang Jinshan’s Research project

1.The National "Eighth Five-Year Plan" Scientific and Technological Key Project—Clinical and Basic Research on Comprehensive Interventional Therapy for Liver Cancer (Project Leader): This project systematically explored multimodal interventional strategies for liver cancer, established the core regimen of superselective TACE combined with local ablation, and significantly improved the therapeutic outcomes for intermediate and advanced liver cancer.

2.The Military "Ninth Five-Year Plan" Key Medical Scientific Research Project—Standardized Research on TIPSS for the Treatment of Portal Hypertension (Project Leader): This project formulated China's first operational standards and postoperative management guidelines for TIPSS, reduced the incidence of complications, and promoted the popularization of this technique throughout the military and across the country.

3.National Natural Science Foundation of China Project — Research on the Mechanism of Targeted Therapy for Liver Cancer Using Hepatic Vein Occlusion Combined with Chemoembolization (Project Leader): This project revealed the synergistic enhancement mechanisms of the innovative technique at the levels of hemodynamics, drug metabolism, and the tumor microenvironment, providing theoretical support for precision interventional therapy of liver cancer.

4.Military Clinical High-Tech Major Project-Establishment and Clinical Application of the Interventional Treatment Technology System for Complex Vascular Diseases (Project Leader): This project overcame interventional challenges in complex lesions such as Budd-Chiari syndrome, peripheral vascular occlusion, and vascular malformations, forming a complete technical system that has been promoted and applied widely.

El Dr. Samuel Moscovici es un neurocirujano de gran prestigio en Jerusalén, especializado en afecciones cerebrales complejas y tratamientos mínimamente invasivos.

• Coautor de 67 artículos revisados por pares en neurocirugía
• Especializado en quistes epidermoides, schwannomas y neurosarcoidosis
• Experto en embolización endovascular y colocación de stents
• Ejerce en el Hadassah Medical Center de Jerusalén

Especialista en neurocirugía con formación avanzada en radiocirugía Gamma Knife – trata tumores cerebrales en el Hospital Municipal de Eskişehir.

• _doctor_7403_años_ de experiencia en neurocirugía
• Ha publicado más de 10 artículos científicos sobre temas de neurocirugía
• Formado en el Departamento de Neurocirugía de la Universidad Fırat
• Becario en el departamento de neurocirugía pediátrica de la Universidad Católica
• Miembro activo de la Sociedad Turca de Neurocirugía

El Dr. Ahmer Arif Shaikh se especializa en oncología quirúrgica de cabeza y cuello, centrándose en el cáncer oral y la rehabilitación funcional en el HCG Manavata Cancer Centre.

• 15 años de experiencia en oncología quirúrgica
• Formación de subespecialidad (fellowship) en oncología quirúrgica de cabeza y cuello
• Experto en cirugías maxilofaciales mayores
• Investigador con múltiples publicaciones

Especializado en radioterapia, el Dr. Van Kampen ofrece tratamientos precisos con CyberKnife en la Clínica Nordwest.

• Se centra en el tratamiento de tumores cerebrales
• Trabaja con técnicas avanzadas de radioterapia
• Forma parte de un equipo especializado en la Clínica Nordwest

Jefe del Departamento de Neurocirugía en la clínica HM Hospitales – especializado en tratamientos avanzados de tumores cerebrales.

• Dirige un equipo de neurocirugía de primer nivel en Madrid
• Experto en terapias de radiación de precisión como CyberKnife
• Se centra en procedimientos mínimamente invasivos para tumores cerebrales